Corcept Therapeutics Inc [NASDAQ: CORT] traded at a high on Monday, posting a 109.08 gain after which it closed the day’ session at $114.22.
The results of the trading session contributed to over 14297377 shares changing hands. Over the past one week, the price volatility of Corcept Therapeutics Inc stands at 10.10% while the volatility over the past one month is 6.36%.
The market cap for CORT stock reached $12.05 billion, with 105.11 million shares outstanding and 93.19 million shares in the current float. Compared to the average trading volume of 995.56K shares, CORT reached a trading volume of 14297377 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Corcept Therapeutics Inc [CORT]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CORT shares is $139.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CORT stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Truist have made an estimate for Corcept Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 06, 2023. While these analysts kept the previous recommendation, SVB Securities raised their target price to Market Perform. The new note on the price target was released on April 11, 2023, representing the official price target for Corcept Therapeutics Inc stock. Previously, the target price had yet another raise to $27, while Piper Sandler analysts kept a Overweight rating on CORT stock. On February 15, 2023, analysts decreased their price target for CORT shares from 35 to 22.
The Average True Range (ATR) for Corcept Therapeutics Inc is set at 7.11, with the Price to Sales ratio for CORT stock in the period of the last 12 months amounting to 17.85. The Price to Book ratio for the last quarter was 17.67, with the Price to Cash per share for the same quarter was set at 3.63. Price to Free Cash Flow for CORT in the course of the last twelve months was 61.51 with Quick ratio for the last quarter at 3.26.
How has CORT stock performed recently?
Corcept Therapeutics Inc [CORT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 92.06. With this latest performance, CORT shares gained by 88.54% in over the last four-week period, additionally plugging by 163.91% over the last 6 months – not to mention a rise of 351.11% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CORT stock in for the last two-week period is set at 86.54, with the RSI for the last a single of trading hit 90.88, and the three-weeks RSI is set at 82.47 for Corcept Therapeutics Inc [CORT]. The present Moving Average for the last 50 days of trading for this stock 62.71, while it was recorded at 68.19 for the last single week of trading, and 48.23 for the last 200 days.
Corcept Therapeutics Inc [CORT]: Deeper insight into the fundamentals
Corcept Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.26 and a Current Ratio set at 3.35.
Earnings analysis for Corcept Therapeutics Inc [CORT]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CORT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Corcept Therapeutics Inc go to 71.00%.
Insider trade positions for Corcept Therapeutics Inc [CORT]
There are presently around $81.80%, or 92.36%% of CORT stock, in the hands of institutional investors. The top three institutional holders of CORT stocks are: BLACKROCK INC. with ownership of 16.54 million shares, which is approximately 16.0391%. VANGUARD GROUP INC, holding 9.55 million shares of the stock with an approximate value of $$310.4 million in CORT stocks shares; and VANGUARD GROUP INC, currently with $$267.66 million in CORT stock with ownership which is approximately 7.989%.
